Featured Clinics:

Study Details
AbbVie is testing an investigational drug, which is not approved by the Food and Drug Administration (FDA) or any health authority and is not currently available on the market. The objective of this study is to compare the safety, tolerability, immunogenicity and pharmacokinetics (the amount of drug absorbed by the body into your blood stream and how your body handles the drug) of a single dose via intravenous dosing.


480 S. Us Highway 45
Grayslake, IL 60030

(800) 827-2778

View Study Website
Sponsored By: AbbVie
Stipend: $0 - $13775
Length of Study: 18 weeks
Research Facility: In-Patient
Gender: Both
Age: 18 - 55
Washout Period: 30 days from Last Dosing Date to Screening
Health Condition: *Healthy Volunteers Studies
 
More Information: Must be first-or second-generarion Han Chinese/Japanese or full Chinese/Japanese parentage

BMI 18-32

Not taking any medications or herbal remedies or supplements
Report inaccurate listing information by clicking here